tiprankstipranks
Exicure Inc (XCUR)
NASDAQ:XCUR
Holding XCUR?
Track your performance easily

Exicure (XCUR) Stock Price & Analysis

882 Followers

XCUR Stock Chart & Stats


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

XCUR FAQ

What was Exicure Inc’s price range in the past 12 months?
Exicure Inc lowest stock price was $0.30 and its highest was $1.34 in the past 12 months.
    What is Exicure Inc’s market cap?
    Currently, no data Available
    When is Exicure Inc’s upcoming earnings report date?
    Exicure Inc’s upcoming earnings report date is Aug 08, 2024 which is 107 days ago.
      How were Exicure Inc’s earnings last quarter?
      Currently, no data Available
      Is Exicure Inc overvalued?
      According to Wall Street analysts Exicure Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Exicure Inc pay dividends?
        Exicure Inc does not currently pay dividends.
        What is Exicure Inc’s EPS estimate?
        Exicure Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Exicure Inc have?
        Exicure Inc has 8,651,148 shares outstanding.
          What happened to Exicure Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Exicure Inc?
          Among the largest hedge funds holding Exicure Inc’s share is Carlson Capital LP. It holds Exicure Inc’s shares valued at N/A.
            ---

            Exicure Stock Smart Score

            Company Description

            Exicure Inc

            Exicure, Inc. engages in the provision of clinical stage biotechnology company. It offers 3-dimensional, spherical nucleic acid architecture unlocks the potential of nucleic acid therapeutics. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Curis
            Cytokinetics
            Kura Oncology
            MacroGenics
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis